In this case report, we present a patient with a therapy-related <i>BCR-JAK2</i> <sup><i>+</i></sup> myeloid neoplasm with extensive extramedullary disease localizing in the lymph nodes. This evidence concerns the gene JAK2 and myeloid neoplasm.